{{Rsnum
|rsid=1532269
|Gene=PDZD2
|Chromosome=5
|position=32018735
|Orientation=minus
|GMAF=0.433
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
|Gene_s=PDZD2
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 47.8 | 44.2 | 8.0
| HCB | 11.7 | 46.0 | 42.3
| JPT | 11.5 | 41.6 | 46.9
| YRI | 3.4 | 34.7 | 61.9
| ASW | 10.7 | 33.9 | 55.4
| CHB | 11.7 | 46.0 | 42.3
| CHD | 15.0 | 54.2 | 30.8
| GIH | 31.7 | 49.5 | 18.8
| LWK | 1.8 | 21.8 | 76.4
| MEX | 19.3 | 49.1 | 31.6
| MKK | 5.1 | 35.9 | 59.0
| TSI | 42.2 | 41.2 | 16.7
| HapMapRevision=28
}}{{PMID Auto
|PMID=21061259
|Title=Genome-wide association study of genetic predictors of anti-tumour necrosis factor (TNF) treatment in rheumatoid arthritis (RA) identifies associations with polymorphisms at seven loci
|OA=1
}}

{{on chip | Affy GenomeWide 6}}